(Q41034036)

English

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term (English)

1 reference

Europe PubMed Central

25 September 2017

4

1 reference

Europe PubMed Central

25 September 2017

author name string

Fernando GJ

1

1 reference

Europe PubMed Central

25 September 2017

Stewart TJ

2

1 reference

Europe PubMed Central

25 September 2017

Tindle RW

3

1 reference

Europe PubMed Central

25 September 2017

publication date

1 May 1998

1 reference

Europe PubMed Central

25 September 2017

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

25 September 2017

47

1 reference

Europe PubMed Central

25 September 2017

5

1 reference

Europe PubMed Central

25 September 2017

459-465

1 reference

Europe PubMed Central

25 September 2017

Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Comparison of adjuvants for immune potentiating properties and side effects in mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Immune deviation: a historical perspective

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

The current status of therapeutic HPV vaccine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

The adjuvanticity of Algammulin, a new vaccine adjuvant.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

ISCOMs (immunostimulating complexes): the first decade

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Long-term effect of primary immunization on subsequent immune responsiveness.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00327.X

21 January 2018

Identifiers

10.1046/J.1365-3083.1998.00327.X

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41034036&oldid=2093360850"